e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Prognosis and diagnosis of thoracic malignancies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Biochemical and cytological features of metastatic pleural effusions in breast cancer
M. Medenica (Niksic, Serbia And Montenegro)
Source:
Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies
Session:
Prognosis and diagnosis of thoracic malignancies
Session type:
Thematic Poster Session
Number:
3905
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Medenica (Niksic, Serbia And Montenegro). Biochemical and cytological features of metastatic pleural effusions in breast cancer. Eur Respir J 2007; 30: Suppl. 51, 3905
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 93s
Year: 2006
Thoracoscopy in malignant pleural effusions secondary to breast cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 611s
Year: 2006
Biochemical parameters in malignant pleural mesothelioma and pulmonary adenocarcinoma
Source: Eur Respir J 2005; 26: Suppl. 49, 74s
Year: 2005
Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005
Pathological diagnosis of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020
Biological characteristics of dendritic cells from malignant pleural effusions in patients with lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 772s
Year: 2006
Oncodrivers in malignant pleural effusions associated with non-small cell lung cancer
Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema
Year: 2020
Timp-2 expression in the cytologic evaluation of adenocarcinoma pleural effusions
Source: Annual Congress 2007 - Pleural malignancy
Year: 2007
Pleural effusion in cases of breast carcinoma
Source: Eur Respir J 2003; 22: Suppl. 45, 62s
Year: 2003
Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011
Epidemiology and clinical problems of orphant pleural adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006
Pleural effusions in lung cancer
Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions
Year: 2012
An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006
Lung cancer and pleural mesothelioma
Source: Eur Respir Monogr 2014; 65: 48-60
Year: 2014
Evaluation of concomitant pleural effusions in patients with lung cancers
Source: Eur Respir J 2007; 30: Suppl. 51, 668s
Year: 2007
Pre-therapeutic staging and prognostic factors in malignant pleural mesothelioma patients
Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines
Year: 2009
Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Ultra-late pleural metastasis of breast cancer: are they so rare?
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021
Diagnostic significance of ADAM8 in non-small cell lung cancer and malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008
Diagnosis and staging of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept